3T Biosciences, Inc

Sonoma Biotherapeutics, located in South San Francisco, is dedicated to developing innovative living cell therapies aimed at restoring balance to the immune system and curing autoimmune and inflammatory diseases. The company builds upon decades of research and is pioneering advancements in Treg biology and cell therapy, focusing on transforming the lives of patients affected by these conditions. With a strong emphasis on scientific validation, Sonoma Biotherapeutics is actively conducting clinical trials for several of its product candidates. The organization is distinguished by its collaborative approach, effectively merging academic expertise with practical execution to address both sides of immune balance. Generated from the website

Gordian Biotechnology, located in South San Francisco, is dedicated to discovering new therapies for complex age-related diseases through its proprietary in vivo drug discovery platform. By utilizing innovative methods such as Patient Avatars and Mosaic Screening, the company aims to identify targets and therapies that are most likely to succeed in human trials. With a mission to enhance the quality of life for individuals facing age-related challenges, Gordian's Pythia approach examines the entire transcriptome to assess the effects of various therapies on cellular pathways. Led by CEO Francisco LePort, the company is committed to enabling people to lead longer, healthier lives. Generated from the website

Nine Square Therapeutics Corp, based in South San Francisco, CA, is a biotechnology firm focused on accelerating the development of innovative drugs targeting neurodegenerative diseases. The company is driven by a commitment to explore solutions beyond the ordinary, aiming to identify and pursue targets previously considered undruggable. With a team of experienced professionals, including experts from renowned institutions, Nine Square Therapeutics leverages a combination of science and partnership to drive innovation in drug discovery. Their multidisciplinary approach emphasizes collaboration and advanced research methodologies to alter the trajectory of diseases such as Alzheimer's and Parkinson's. Generated from the website